By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Big Week for Earnings as Tech, Auto Giants Report Q3 Results
A stacked week of earnings this week as Facebook, Twitter, Amazon and several others gear up to release their quarterly results. Earnings have so far exceeded expectations despite supply chain concerns and the ongoing pandemic. Daniel Newman, Futurum Research principal analyst, tells Cheddar which companies he's paying attention to this week.
Babylon Makes Public Debut on NYSE
Ali Parsa, Founder & CEO of Babylon, discusses the need for healthcare monitoring to prevent sickness and how technology improves access to quality care.
Covid Vaccines for Children Ages 5-11 Could Be Coming at Any Moment
The FDA meets today on whether or not vaccines for children ages 5-11 can potentially become available to the public. Cheddar News was joined by Dr. Richard Besser, President and CEO of the Robert Wood Johnson Foundation and former Acting Director of the CDC to discuss what could come next for these vaccines.
SPAC Linked to President Trump Sees Massive Boom
Last week, shares of Digital World Acquisition Corp skyrocketed after following Former Present Trump's announcement that he would be partnering with the company as part of a Special Purpose Acquisition Company, or SPAC. Christian Munafo, Chief Investment Officer of Liberty Street Advisors and portfolio Manager of the Private Shares Fund broke down the latest, including whether or not Wall Street is currently experiencing a SPAC boom.
Breaking Down Facebook Earnings Beat, Miss on Revenue
Facebook reported a beat on its Q3 earnings on Monday, despite a miss on revenue. This comes as the social media giant has found itself entrenched in negative headlines of late. Timothy Lesko, Partner and Portfolio Manager at Granite Investment Advisors, joined Cheddar to break down the latest.
What Facebook Earnings Indicate About Its Future Outlook
Facebook has been in the midst of a media firestorm thanks to the Wall Street Journal scathing report and Frances Haugen's whistleblowing among other news. With the social media giant set to release its Q3 earnings after the bell, Cheddar News caught up with John Quelch, Dean of Miami Herbery Business School to discuss what to expect.
Load More